27 October 2020
PMI scientists presented at the 3rd Scientific Summit in Greece, which was held virtually September 24-25 this year. The conference aims to address Tobacco Harm Reduction and bring in thought leaders worldwide to discuss and present the different vital facts and figures related to the topic of Tobacco Harm Reduction.
Typically held in Athens, Greece, the conference went virtual this year--an approach that has been taken at many scientific conference during 2020 because of the COVID-19 pandemic. As in previous years, this conference focuses on novel tobacco products, as well as the research and policies surrounding them.
You can learn more about the conference, or scroll down to watch the recorded presentations and download the presentation PDF files.
Toxicological assessment of flavored e-liquids in Sprague Dawley rats in an OECD subchronic inhalation study complemented by systems toxicology endpoints
Presented by Dr. Davide Sciuscio, Manager Pre-Clinical Toxicology Evaluation
Tobacco Heating System 2.2 in mild to moderate chronic obstructive pulmonary disease subjects: an exploratory analysis
Presented by Dr. Fancesco Sergio, Medical Director
A proposed approach for evaluating harm reduction in adult smokers after switching from cigarettes to tobacco heating system (THS): biomarkers of potential harm
Presented by Dr. Christelle Haziza, Director Clinical Science and Biostatistics
Systems toxicology assessment of a representative e-liquid formulation by using human primary bronchial epithelial cells
Presented by Dr. Diego Marescotti, Manager High Content Screening
IQOS uptake and history of tobacco product use: findings from cross-sectional surveys in Japan, Italy, and Germany
Presented by Steve Roulet, Global Head of Behavioral Research Insights